Boehringer Ingelheim developed the only licensed blood clot dissolving treatment (thrombolytic) for acute ischaemic stroke therapy, now used worldwide.
Donations of Protective Materials to Healthcare Institutions
Boehringer Ingelheim Mexico donated protective materials to governmental health institutions dedicated to the care of patients with COVID-19. Learn more.
Faced with COVID-19, everyone has to adjust their lives, which can be challenging. This is especially true for healthcare professionals. Find out more.